Startup Waiv Spins Out of Owkin With $33M to Bring AI Precision to Cancer Decisions – MedCity News
Cancer treatment is evolving with a growing number of therapies designed to address specific targets expressed by tumors or genetic…
Cancer treatment is evolving with a growing number of therapies designed to address specific targets expressed by tumors or genetic…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line…